Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Chronic Stress (Thousand Oaks, Calif.)|July 24, 2018
Cerebellar and prefrontal cortical alterations in PTSD: structural and functional evidenceSophie E Holmes, Dustin Scheinost, Nicole DellaGioia, et al.
Biological Psychiatry|December 1, 2025
Neural Signatures of Bipolar Disorder and Psychotropic Medication Effects: A Multimodal PET-MRI StudyRuth H Asch, Siyan Fan, Ryan Cool, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 26, 2017
Multimodal Investigation of Network Level Effects Using Intrinsic Functional Connectivity, Anatomical Covariance, and Structure-to-Function Correlations in Unmedicated Major Depressive DisorderDustin Scheinost, Sophie E Holmes, Nicole DellaGioia, et al.
Brain, Behavior, and Immunity|July 16, 2013
The neuroinflammation marker translocator protein is not elevated in individuals with mild-to-moderate depression: a [¹¹C]PBR28 PET studyJonas Hannestad, Nicole DellaGioia, Jean-Dominique Gallezot, et al.
Biological Psychiatry|August 27, 2014
In vivo ketamine-induced changes in [¹¹C]ABP688 binding to metabotropic glutamate receptor subtype 5Christine DeLorenzo, Nicole DellaGioia, Michael Bloch, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 16, 2019
In vivo evidence for dysregulation of mGluR5 as a biomarker of suicidal ideationMargaret T Davis, Ansel Hillmer, Sophie E Holmes, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|November 21, 2019
Measuring the effects of ketamine on mGluR5 using [18F]FPEB and PETSophie E Holmes, Jean-Dominique Gallezot, Margaret T Davis, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 19, 2017
Altered metabotropic glutamate receptor 5 markers in PTSD: In vivo and postmortem evidenceSophie E Holmes, Matthew J Girgenti, Margaret T Davis, et al.
Biological Psychiatry|February 10, 2023
Differences in Quantification of the Metabotropic Glutamate Receptor 5 Across Bipolar Disorder and Major Depressive DisorderSophie E Holmes, Ruth H Asch, Margaret T Davis, et al.
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging|October 11, 2017
Metabotropic Glutamate Receptor 5 and Glutamate Involvement in Major Depressive Disorder: A Multimodal Imaging StudyChadi G Abdallah, Jonas Hannestad, Graeme F Mason, et al.
Pageof 3